Chronic Health

Yes. The mental health impact of a chronic illness diagnosis is well documented in the clinical literature, and feeling depressed in the months after one is a recognised response, not a sign that something has gone wrong. What is useful to know is the shape distress tends to take and how long it tends to last. Research that has followed people across the period after a chronic illness diagnosis identifies several different trajectories rather than a single common pattern. For most people, distress eases as adjustment proceeds. A smaller group experiences difficulty that persists, and a smaller group again experiences difficulty that arrives late. A GP is the appropriate first contact if low mood does not lift.

Medical gaslighting is the term that has emerged in the sociological and clinical literature to describe a recognisable pattern: a person's account of their own symptoms is dismissed, minimised, or attributed to a psychological cause when a physical one is present. It is not a formal diagnosis. It is a description of an experience that has been studied. The psychological consequences of repeated exposure to the pattern are now well documented, and they sit separately from the missed diagnosis itself.

Endometriosis affects around 1 in 7 Australian women born between 1973 and 1978, by age 44 to 49 (Australian Institute of Health and Welfare, 2023). What that figure does not tell you is how much of that population is also carrying a significant mental health load. Research that has followed Australian women over decades has found that women with endometriosis have close to twice the odds of depression and anxiety compared to women without the condition. When I am working with clients with endometriosis, the mental health impact is not usually one thing. It is a cluster of things layered on top of each other, and the pain, which the world tends to focus on, is often not the loudest layer.

PCOS affects around 1 in 8 Australian women of reproductive age (Teede et al., 2024). The mental health impact is substantial and well documented, and the picture in the research has been getting more textured year by year. There are two parts worth understanding: the mental health symptoms most often documented in women with PCOS, and the emerging picture around overlap with ADHD. The second part is one of the more interesting emerging areas in this field, and it is worth being careful about how we describe it.

The honest answer is that exhaustion in chronic illness usually has more than one source, and distinguishing them is part of what makes the assessment useful. Three possibilities sit alongside each other and often overlap: depression, a fatigue syndrome such as ME/CFS, or the cumulative weight of an underlying chronic condition. Each responds to different attention, which is why the differential matters. A GP-led assessment, with a psychologist working alongside where useful, is what tends to make the picture clear.

You do not grieve her the way you would grieve someone who has died. There is no funeral, no anniversary, no one bringing food. The pre-illness self is gone, but you are still here, in a body that has changed. And she is still around, sometimes, on a good week, in the shape of who you used to be. That makes the standard grief scripts (the five stages, the year of mourning, the eventual closure) not quite fit. What helps is not following a script. It is recognising what this kind of grief actually looks like, and giving it the room it needs without rushing it.

The conversation you are imagining is harder to start than to have. Most of the couples I work with arrive having put it off, sometimes for months, sometimes for years, because the cost of saying it out loud feels higher than the cost of leaving it unsaid. The research disagrees. Or more precisely, the research suggests that the conversations that do not happen tend to do more harm than the ones that do. What helps most is not a perfect script. It is the willingness to name what has already shifted, gently, and to do it as a "we."

The decision to tell work is not one decision. It is a series of them: who to tell, how much, when, in what setting, with what supporting documentation. There is no universal right answer, because the calculation depends on you, your workplace, your role, and your needs. What is universal is that the decision is psychological as much as practical, and the psychological piece is often what is hardest to think clearly about. A few things help.

The anxiety that follows a cancer diagnosis is recognised in the clinical literature, well documented, and has a measurable shape. The most-studied form is what is called fear of cancer recurrence (FCR), defined in the clinical-consensus literature as fear, worry, or concern relating to the possibility that cancer will come back or progress (Lebel et al., 2016). FCR sits between two extremes: a passing thought that does not affect daily life, and a clinically significant pattern that does. The middle ground is where most people are, and it shifts over time.

The overlap between chronic illness and neurodivergence is an area where clinical understanding has shifted considerably in the past five years. Three pieces of research are useful to know. The first describes a documented association between joint hypermobility (and the conditions that travel with it) and autistic and ADHD presentations. The second names autistic burnout as distinct from depression and from ordinary fatigue. The third reframes communication difficulty in healthcare encounters as bidirectional, not as a unilateral deficit. Together, they shape what changes when both pictures are present at once.